TMEM163
Basic information
Region (hg38): 2:134455759-134719000
Links
Phenotypes
GenCC
Source:
- leukodystrophy, hypomyelinating, 25 (Limited), mode of inheritance: AD
- leukodystrophy, hypomyelinating, 25 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, hypomyelinating, 25 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 35455965; 35953447 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM163 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 20 | 0 | 0 |
Variants in TMEM163
This is a list of pathogenic ClinVar variants found in the TMEM163 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-134456750-A-G | not specified | Uncertain significance (Feb 28, 2024) | ||
2-134456751-C-T | not specified | Uncertain significance (Dec 14, 2021) | ||
2-134456756-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
2-134458030-A-G | Leukodystrophy, hypomyelinating, 25 | Uncertain significance (Sep 13, 2024) | ||
2-134458047-A-T | not specified | Uncertain significance (Apr 15, 2022) | ||
2-134458057-G-C | not specified | Uncertain significance (Oct 28, 2023) | ||
2-134458089-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
2-134458150-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
2-134466168-C-T | not specified | Uncertain significance (Aug 08, 2023) | ||
2-134466201-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
2-134502978-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
2-134502993-A-C | Uncertain significance (Jul 15, 2022) | |||
2-134550582-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
2-134550591-T-C | Leukodystrophy, hypomyelinating, 25 | Pathogenic (Feb 14, 2023) | ||
2-134550594-A-T | Leukodystrophy, hypomyelinating, 25 | Uncertain significance (Mar 29, 2024) | ||
2-134550616-G-A | Leukodystrophy, hypomyelinating, 25 | Pathogenic (Feb 14, 2023) | ||
2-134713278-G-T | Uncertain significance (Dec 14, 2023) | |||
2-134713295-A-C | Leukodystrophy, hypomyelinating, 25 | Pathogenic (Feb 14, 2023) | ||
2-134713295-A-G | Leukodystrophy, hypomyelinating, 25 | Likely pathogenic (Nov 07, 2022) | ||
2-134718745-A-C | not specified | Uncertain significance (Jul 11, 2023) | ||
2-134718778-C-T | not specified | Uncertain significance (Sep 13, 2022) | ||
2-134718783-C-G | not specified | Uncertain significance (Mar 22, 2023) | ||
2-134718796-T-A | not specified | Uncertain significance (Sep 01, 2021) | ||
2-134718826-C-T | not specified | Uncertain significance (Apr 14, 2022) | ||
2-134718836-C-G | not specified | Uncertain significance (Dec 08, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMEM163 | protein_coding | protein_coding | ENST00000281924 | 8 | 263241 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0397 | 0.933 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.77 | 85 | 145 | 0.587 | 0.00000885 | 1859 |
Missense in Polyphen | 23 | 54.37 | 0.42303 | 635 | ||
Synonymous | -0.00432 | 64 | 64.0 | 1.00 | 0.00000470 | 612 |
Loss of Function | 1.91 | 4 | 10.8 | 0.372 | 4.56e-7 | 150 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May bind zinc and other divalent cations and recruit them to vesicular organelles. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.267
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.305
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.570
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.450
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmem163
- Phenotype
- embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype;
Gene ontology
- Biological process
- zinc ion import into synaptic vesicle
- Cellular component
- cell junction;integral component of synaptic vesicle membrane;early endosome membrane
- Molecular function
- zinc ion binding